Related references
Note: Only part of the references are listed.Skin Involvement in Paediatric Patients with Type 1 Diabetes
Stefano Passanisi et al.
CURRENT DIABETES REVIEWS (2022)
Continuous glucose monitoring systems give contact dermatitis in children and adults despite efforts of providing less 'allergy- prone' devices: investigation and advice hampered by insufficient material for optimized patch test investigations
C. Svedman et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2021)
7. Diabetes Technology: Standards of Medical Care in Diabetes-2021
DIABETES CARE (2021)
Comparison of Continuous Subcutaneous Insulin Infusion and Multiple Daily Injections in Pediatric Type 1 Diabetes: A Meta-Analysis and Prospective Cohort Study
Xu Wang et al.
FRONTIERS IN ENDOCRINOLOGY (2021)
Contact Dermatitis: Classifications and Management
Yan Li et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2021)
Continuous Glucose Monitoring Improves Glycemic Outcomes in Children With Type 1 Diabetes: Real-World Data From a Population-Based Clinic
Elaine E. Sanderson et al.
DIABETES CARE (2021)
Efficacy of advanced hybrid closed loop systems for the management of type 1 diabetes in children
Lucia Ferrito et al.
MINERVA PEDIATRICS (2021)
High Frequency of Dermatological Complications in Children and Adolescents with Type 1 Diabetes: A Web-Based Survey
Fortunato Lombardo et al.
JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY (2021)
Five-Month Follow-up Shows No Improvement in Dermatological Complications in Children With Type 1 Diabetes Using Continuous Glucose Monitoring Systems and Insulin Pumps
Anna T. Weng et al.
JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY (2021)
High Prevalence of Skin Reactions Among Pediatric Patients with Type 1 Diabetes Using New Technologies: The Alarming Role of Colophonium
Fortunato Lombardo et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2020)
Out of the box solution for skin problems due to glucose-monitoring technology in youth with type 1 diabetes: real-life experience with fluticasone spray
Michal Paret et al.
ACTA DIABETOLOGICA (2020)
Type 1 diabetes mellitus management in young children: implementation of current technologies
Michal Nevo-Shenker et al.
PEDIATRIC RESEARCH (2020)
Prevalence and Prevention of Contact Dermatitis Caused by FreeStyle Libre: A Monocentric Experience
Jeroen Pyl et al.
DIABETES CARE (2020)
Prevalence of contact dermatitis to glucose sensors in pediatric population and the main allergens involved
Carmen Vidal-Albareda et al.
CONTACT DERMATITIS (2020)
Allergic contact dermatitis in pediatric patients with type 1 diabetes: An emerging issue
Fortunato Lombardo et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2020)
Effect of Continuous Glucose Monitoring on Glycemic Control in Adolescents and Young Adults With Type 1 Diabetes A Randomized Clinical Trial
Lori M. Laffel et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Quality of Life in Children With Diabetes Treated With Insulin Pump Compared With Multiple Daily Injections in Tertiary Care Center
Adnan Al Shaikh et al.
CLINICAL MEDICINE INSIGHTS-ENDOCRINOLOGY AND DIABETES (2020)
Skin Problems Due to Treatment with Technology Are Associated with Increased Disease Burden Among Adults with Type 1 Diabetes
Maria O. Christensen et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2019)
Allergic contact dermatitis caused by glucose sensors in type 1 diabetes patients
Heli S. I. Hyry et al.
CONTACT DERMATITIS (2019)
Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range
Tadej Battelino et al.
DIABETES CARE (2019)
Benefits and Barriers of Continuous Glucose Monitoring in Young Children with Type 1 Diabetes
Marisa E. Hilliard et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2019)
Isobornyl acrylate contained in the insulin patch pump OmniPod as the cause of severe allergic contact dermatitis
Eva Oppel et al.
CONTACT DERMATITIS (2018)
Allergic contact dermatitis caused by isobornyl acrylate in OmniPod, an innovative tubeless insulin pump
Nadia Raison-Peyron et al.
CONTACT DERMATITIS (2018)
Allergic contact dermatitis and diabetes medical devices: 2 clinical cases
Stefano Passanisi et al.
CONTACT DERMATITIS (2018)
Duration of Catheter Use in Patients with Diabetes Using Continuous Subcutaneous Insulin Infusion: A Review
Lisa Bonato et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2018)
Preserving Skin Integrity with Chronic Device Use in Diabetes
Laurel H. Messer et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2018)
Allergic contact dermatitis caused by medical devices for diabetes patients: A review
Anne Herman et al.
CONTACT DERMATITIS (2018)
Perception and Possible Causes of Skin Problems to Insulin Pump and Glucose Sensor: Results from Pediatric Focus Groups
Anna Korsgaard Berg et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2018)
Allergic contact dermatitis caused by isobornyl acrylate in Freestyle® Libre, a newly introduced glucose sensor
Anne Herman et al.
CONTACT DERMATITIS (2017)
British Association of Dermatologists' guidelines for the management of contact dermatitis 2017
G. A. Johnston et al.
BRITISH JOURNAL OF DERMATOLOGY (2017)
Frequency of Dermatological Side Effects of Continuous Subcutaneous Insulin Infusion in Children and Adolescents with Type 1 Diabetes
E. Binder et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2015)
Contact Dermatitis: A Practice Parameter-Update 2015
Luz Fonacier et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2015)
Contact dermatitis in children
Paolo Pigatto et al.
ITALIAN JOURNAL OF PEDIATRICS (2010)
Contact dermatitis in children
Paolo Pigatto et al.
ITALIAN JOURNAL OF PEDIATRICS (2010)
New Definition for the Partial Remission Period in Children and Adolescents with Type 1 Diabetes
Henrik B. Mortensen et al.
DIABETES CARE (2009)
Evidence-based diagnosis in patch testing
PGM van der Valk et al.
CONTACT DERMATITIS (2003)
Share Paper
